glaxo 1 1

Tag: "glaxo" at medical news

Glaxo launches pills to help smokers quit in 7-12 weeks

GLAXO SmithKline India has launched an oral treatment for smoking, called Zyban. The pill (generic - Bupropion Hydrochloride) is reportedly the first product aimed at stopping smoking and is available at Rs. 40 per tablet. Speaking to newspersons, Mr. Kalyanasundaram, Director (Pharmaceuticals), Glaxo India Ltd, said the complete treatment osts about Rs. 5000 and takes about 7-12 weeks. ..In th...

GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging

Lamictal, an antiepileptic drug, is one of the several prescription drugs that has encountered the problem of dispensing errors. ..Dispensing errors are often a result of miscommunication, which can include poor hand writing of the prescription and confusion between drugs with similar names.// ....It is important for patients with epilepsy not to have an interruption in treatment because it could...

GlaxoSmithKline To Cultivate Non-Smoking Environment

GlaxoSmithKline is putting its best foot forward in completing its social responsibility. The steps will also enable the company promote Zyban, its anti-smoking drug. Glaxo is aiding companies cultivate a non-smoking environment as part of its policy, along with providing teams to help in the transition. // ....Some of the corporate, which have negotiated for this 'no-smoking' environment, are H...

GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix

GlaxoSmithKline will supply 8 million doses of its flu vaccine, Fluarix. This dosage is twice the amount GSK shipped to US last year. This amount of 8 million doses only represents about 10% of the demand from the US, due to increased need for vaccines against flu.// The immense need for vaccination increased due to large vaccination awareness programs organized in the US during recent years, due...

FDA Mislead On Asthma Drug By GlaxoSmithKline

Charges have been held against, a London based leading drug company, GlaxoSmithKline for having presented incorrect data regarding an anti-asthmatic drug, Serevent to the U.S. Food and Drug Administration two years ago when the // medicine came up for a review. This became evident last November when The FDA identified Serevent as a drug that needed additional warnings. .. ..The Public Citizen Gro...

GlaxoSmithKline Defends Its Products

Pharmaceutical company GlaxoSmithKline which produces Panadol products like Panadol Extra has sought to dispel doubts with regard to the safety of its products. People in the Middle East Region // are reported to have received messages questioning the safety with regard to particular batch of its products, namely batch number 050292. ....The company has confirmed the safety of the products afte...

GlaxoSmithKline launches diabetes and cancer drugs

GlaxoSmithKline is in a spree of producing new diabetes and cancer drugs which it hopes will increase its sales this year. After the recent U.S. drug approvals it is starting // to market two of its new diabetes drug Avandaryl and Avandamet which is found to be effective in treating type 2 diabetes. ..The drug Avandaryl is manufactured by combining the two drugs Avandina and Sulphonylureas and t...

Generic Products Compete With GlaxoSmithKline

Stiff competition offered by generic drug makers may well eat into the profit figures of GlaxoSmithKline, according to company sources. The Cox-2 painkiller of the organization is also likely to suffer as a result of this.// The company is also embroiled in a tax related dispute with the Government in the US. The sales of the company for the year rose by13% at ￡21.6 billion, while its earnings w...

New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline

Cervarix, a cervical cancer vaccine produced by Glaxo Smithkline (Britain's biggest drug manufacturer) is being registered for approval// by the European regulatory authority. If approved, the vaccine would be marketed for commercial use, by the end of next year. ....Gardasil, a similar vaccine produced by the US pharmaceuticals giant Merck has already been registered for use in the US. It has...

GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million

GlaxoSmithKline (GSK) has reached an agreement with Eliot Spitzer, New York Attorney General to settle claims that it deceptively tried to delay competitors from releasing the generic versions of its star anti-depressant drug Paxil.// ..GSK was allegedly involved in a shady enterprise to keep the generic producers of Paxil in a bind of using frivolous patent-infringement lawsuits, thus managin...

GlaxoSmithKline's Zofran Helps In Treatment Of Dehydration In Children

The drug Zofran, commonly given in children to limit vomiting can help in the recovery of children dehydrated by viral gastroenteritis //. A latest study released on Wednesday further highlights that emergency room doctors are overusing the drug. ....Childhood gastroenteritis accounts for over 1.5 million of the emergency room visits annually. Dehydrated children are being encouraged to drink an...

Ranbaxy Acquires Glaxosmithkline's Generic Unit in Spain

Looking to expand its presence and product portfolio in the Spanish market, pharma major Ranbaxy Laboratories Ltd today said it has acquired GlaxoSmithKline's Mundogen generic business in Spain. // ....Ranbaxy's CEO and MD Malvinder Mohan Singh said that the acquisition was in line with the company's M&A strategy to focus on the EU markets... ..The company said in a filing with the Bombay Stock...

GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD

The Food and Drug Administration. has given GlaxoSmithKline PLC's anti-seizure medicine to treat Primary Generalized Tonic-Clonic, or PGTC, the green signal.// ..According to GlaxoSmithKline, the U.K. pharmaceutical company, the drug, Lamictal, has been approved to treat children age two and older, as well as adults. ..PGTC seizures are said to be the most-serious and most-commonly occurring ty...

'Daronrix', Glaxo's Bird-flu Vaccine Approved by European Medicines Agency

London – 'Daronrix', Glaxo's bird-flu vaccine, will hold a pride of place in the annals of preventive medicine, to be the first experimental bird-flu //vaccine to receive certification by the European Medicines Agency, for its use in protecting people in the event of a bird-flu pandemic. .. ..This first generation vaccine can be used only after the WHO or the European Union officially declares...

GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find

London: Statistics from a Phase III study has shown that GlaxoSmithKline's Tykerb along with Roche's Xeloda is far better than Xeloda alone in women with HER2// positive advanced breast cancer, where the disease had progressed despite previous therapy involving Herceptin. ....Basis the findings, researchers opined that, Tykerb should be checked out for its use during the early treatment of HER2...

Acid Test - Glaxo's Cervarix, and Merck's Gardasil, Compete

GlaxoSmithKline Plc, Europe's pharmaceutical giant, is finalizing its plan of action, to test its experimental// vaccine Cervarix against Merck & Co.'s Gardasil, in a bid to establish the most effective vaccine against cervical cancer. ....The study, which will be conducted in the United States, will seek to evaluate the immune responses of women aged 18 to 26 years old, to two strains of the hu...

Glaxo Files Cancer Drug For Approval With FDA

Tykerb, a breast cancer drug from Glaxo Smithkline has been filed for approval with America’s FDA and European regulators//. The result of this approval will be known by March 13 and by September in US and Europe respectively. ..According to the company sources, this drug is expected to generate ￡ 1 bn a year not only from treating breast cancer but also from brain and kidney carcinomas. Navid M...

GlaxoSmithKline Signs Outsourcing Deal With TCS

GlaxoSmithKline (GSK), Britain's largest drug company, // has signed an outsourcing deal with India's Tata Consulting Services to establish a drug development support facility in Mumbai. ....A company statement said that under the terms of the deal, TCS will support GSK's global clinical research and development programme by providing outsourced data management and medical trial reporting servi...

GlaxoSmithKline, Brazil Expected To Sign Deal on Providing Antiretroviral at Reduced Cost

GlaxoSmithKline and Brazil by Friday are expected to sign an agreement that would reduce the cost of GSK's antiretroviral Abacavir by 27% in the country , an unnamed health ministry official announced on Thursday, Dow Jones reports. ......Although the official did not specify how much Brazil would save from the deal, he said that GSK likely will lower the cost of Abacavir from $2.76 per dose to...